Use of a thrombus extraction catheter (Thrombuster II(R)) in an acute myocardial infarction

Steve Ramcharitar1, Georgios Sianos, Willem J Van der Giessen

  • 1The Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.

Insights

Thrombectomy devices aim to prevent microvascular clogging during ST-elevated myocardial infarction (STEMI) PCI. The Thrombuster II device shows promise for improving outcomes by enhancing clot aspiration during acute myocardial infarction treatment.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Microvascular clogging from debris embolization during primary percutaneous intervention (PCI) for ST-elevated myocardial infarction (STEMI) impairs myocardial perfusion, increasing infarct size and reducing survival.
  • Suboptimal myocardial blush and delayed ST-segment resolution are clinical indicators of microvascular dysfunction post-PCI.
  • Existing thrombectomy and distal protection devices have shown mixed results in improving microcirculation and clinical outcomes.

Purpose of the Study:

  • To evaluate the technical aspects and application of the Thrombuster II thrombectomy device.
  • To assess the potential of the Thrombuster II to improve microvascular perfusion in acute ST-elevated myocardial infarction (STEMI) patients undergoing primary PCI.

Main Methods:

  • Technical report detailing the design and features of the Thrombuster II device, emphasizing its low frictional resistance and large lumen for superior aspiration.
  • Description of the device's use in the context of primary PCI for acute ST-elevated myocardial infarction (STEMI).

Main Results:

  • The Thrombuster II is designed for efficient clot aspiration, potentially mitigating microvascular obstruction.
  • Its design characteristics suggest improved ability to clear thrombotic material compared to other devices.
  • The report details the practical application of this device in a clinical setting for STEMI.

Conclusions:

  • The Thrombuster II device offers a potentially effective solution for managing thrombotic burden during primary PCI in STEMI.
  • Further clinical studies are warranted to confirm its efficacy in improving microvascular function and patient outcomes.
  • The device's design may address limitations of previous thrombectomy strategies, particularly in cases with high thrombotic load.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...